Showing results (281-290 of 371) with videos related to
Sort By:
Pageof 38
European Journal of Pharmacology|August 7, 1985
Mesolimbic dopaminergic neurons are not spared by MPTP neurotoxicity in miceE Melamed, J Rosenthal, M Globus, et al.European Journal of Pain (London, England)|April 5, 2012
Contribution of genetic variants to pain susceptibility in Parkinson diseaseL Greenbaum, I Tegeder, Y Barhum, et al.Immunological Investigations|August 1, 1995
IL-3-LA production by mononuclear cells of patients with multiple sclerosis: effect of treatment with intravenous immunoglobulinsR Djaldetti, A Achiron, I Ziv, et al.Research Square|June 5, 2026
Leveraging Dog Models to Uncover Human Cancer InsightsGeesa Daluwatumulle, Leslie A Smith, Nathan Glen, et al.Journal of Orthopaedic Trauma|January 1, 1991
Multicenter trial of Collagraft as bone graft substituteC N Cornell, J M Lane, M Chapman, et al.The Annals of Pharmacotherapy|December 16, 2017
Evaluating the Impact of the Addition of Cladribine to Standard Acute Myeloid Leukemia Induction TherapyNathan D Seligson, Athena L V Hobbs, Joanna M Leonard, et al.The New England Journal of Medicine|July 21, 1983
The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemiaJ S Weiss, A Gautam, J J Lauff, et al.Molecular and Cellular Endocrinology|August 1, 1983
Hippocampal cell nuclear binding of corticosterone following 5,7-dihydroxytryptamineR A Siegel, J Weidenfeld, M Chen, et al.Brain Research|December 16, 1985
In vivo effect of MPTP on monoamine oxidase activity in mouse striatumE Melamed, M B Youdim, J Rosenthal, et al.Neuroscience Letters|December 18, 2001
Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson's diseaseD Offen, B Shtaif, D Hadad, et al.Pageof 38